He graduated from Sun Yat-sen University of Medical Sciences in 1982, and completed his thoracic surgery training in Germany in 1989. His main research interests are the multidisciplinary synthetic therapy on lung cancer in translation medicine and evidence-based medicine in oncology. He is active in oncology research and has been principal investigator or steering committee member of more 60 international or national clinical trials. Professor Wu has published 16 books and more than 300 papers in international and national peer-reviewed journals including J Clin Oncol, Lancet Oncol, New Engl J Med and J Thorac Oncol. He also serves on the editorial boards of Cancer Letters, Annals of Surgical Oncology, Lung Cancer, Lung Cancer Management, International Journal of Biological Marker and General Thoracic and Cardiovascular Surgery. He is editor-in-chief of Journal of Evidence-based Medicine, Editor-in-chief of Journal of Thoracic Oncology (Chinese Edition), and Editor-in-chief of Oncologist (Chinese Edition) etc.
He will serve on the IASLC Board of Directors for four years, starting at the WCLC in 2013.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
April 15 - 18 2015Geneva, Switzerland
April 30 2015Omaha, NE
May 2 2015Seattle, WA